Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 132 of 132 entries
Sorted by: Best Match Show Resources per page
Revealing hidden antiferromagnetic correlations in doped Hubbard chains via string correlators.

Science (New York, N.Y.)

Hilker TA, Salomon G, Grusdt F, Omran A, Boll M, Demler E, Bloch I, Gross C.
PMID: 28774925
Science. 2017 Aug 04;357(6350):484-487. doi: 10.1126/science.aam8990.

Topological phases, like the Haldane phase in spin-1 chains, defy characterization through local order parameters. Instead, nonlocal string order parameters can be employed to reveal their hidden order. Similar diluted magnetic correlations appear in doped one-dimensional lattice systems owing...

Cite
Hilker TA, Salomon G, Grusdt F, et al. Revealing hidden antiferromagnetic correlations in doped Hubbard chains via string correlators. Science. 2017;357(6350):484-487doi: 10.1126/science.aam8990.
Hilker, T. A., Salomon, G., Grusdt, F., Omran, A., Boll, M., Demler, E., Bloch, I., & Gross, C. (2017). Revealing hidden antiferromagnetic correlations in doped Hubbard chains via string correlators. Science (New York, N.Y.), 357(6350), 484-487. https://doi.org/10.1126/science.aam8990
Hilker, Timon A, et al. "Revealing hidden antiferromagnetic correlations in doped Hubbard chains via string correlators." Science (New York, N.Y.) vol. 357,6350 (2017): 484-487. doi: https://doi.org/10.1126/science.aam8990
Hilker TA, Salomon G, Grusdt F, Omran A, Boll M, Demler E, Bloch I, Gross C. Revealing hidden antiferromagnetic correlations in doped Hubbard chains via string correlators. Science. 2017 Aug 04;357(6350):484-487. doi: 10.1126/science.aam8990. PMID: 28774925.
Copy Download .nbib Format: NLM
Author Correction: Direct observation of incommensurate magnetism in Hubbard chains.

Nature

Salomon G, Koepsell J, Vijayan J, Hilker TA, Nespolo J, Pollet L, Bloch I, Gross C.
PMID: 30670874
Nature. 2019 Feb;566(7743):E5. doi: 10.1038/s41586-019-0906-z.

In this Letter, the affiliation for Christian Gross should have been 'Max-Planck-Institut für Quantenoptik, Garching, Germany' instead of 'Fakultät für Physik, Ludwig-Maximilians-Universität, Munich, Germany'; this has been corrected online.

Cite
Salomon G, Koepsell J, Vijayan J, et al. Author Correction: Direct observation of incommensurate magnetism in Hubbard chains. Nature. 2019;566(7743):E5doi: 10.1038/s41586-019-0906-z.
Salomon, G., Koepsell, J., Vijayan, J., Hilker, T. A., Nespolo, J., Pollet, L., Bloch, I., & Gross, C. (2019). Author Correction: Direct observation of incommensurate magnetism in Hubbard chains. Nature, 566(7743), E5. https://doi.org/10.1038/s41586-019-0906-z
Salomon, Guillaume, et al. "Author Correction: Direct observation of incommensurate magnetism in Hubbard chains." Nature vol. 566,7743 (2019): E5. doi: https://doi.org/10.1038/s41586-019-0906-z
Salomon G, Koepsell J, Vijayan J, Hilker TA, Nespolo J, Pollet L, Bloch I, Gross C. Author Correction: Direct observation of incommensurate magnetism in Hubbard chains. Nature. 2019 Feb;566(7743):E5. doi: 10.1038/s41586-019-0906-z. PMID: 30670874.
Copy Download .nbib Format: NLM
c-Kit modifies the inflammatory status of smooth muscle cells.

PeerJ

Song L, Martinez L, Zigmond ZM, Hernandez DR, Lassance-Soares RM, Selman G, Vazquez-Padron RI.
PMID: 28626608
PeerJ. 2017 Jun 13;5:e3418. doi: 10.7717/peerj.3418. eCollection 2017.

BACKGROUND: c-Kit is a receptor tyrosine kinase present in multiple cell types, including vascular smooth muscle cells (SMC). However, little is known about how c-Kit influences SMC biology and vascular pathogenesis.METHODS: High-throughput microarray assays and RESULTS: The microarray analysis...

Cite
Song L, Martinez L, Zigmond ZM, et al. c-Kit modifies the inflammatory status of smooth muscle cells. PeerJ. 2017;5:e3418doi: 10.7717/peerj.3418.
Song, L., Martinez, L., Zigmond, Z. M., Hernandez, D. R., Lassance-Soares, R. M., Selman, G., & Vazquez-Padron, R. I. (2017). c-Kit modifies the inflammatory status of smooth muscle cells. PeerJ, 5e3418. https://doi.org/10.7717/peerj.3418
Song, Lei, et al. "c-Kit modifies the inflammatory status of smooth muscle cells." PeerJ vol. 5 (2017): e3418. doi: https://doi.org/10.7717/peerj.3418
Song L, Martinez L, Zigmond ZM, Hernandez DR, Lassance-Soares RM, Selman G, Vazquez-Padron RI. c-Kit modifies the inflammatory status of smooth muscle cells. PeerJ. 2017 Jun 13;5:e3418. doi: 10.7717/peerj.3418. eCollection 2017. PMID: 28626608; PMCID: PMC5472039.
Copy Download .nbib Format: NLM
Safety and Efficacy of Stabilized Hyaluronic Acid Gel for Breast Enhancement.

Plastic and reconstructive surgery. Global open

Hedén P, Sarfati I, Clough K, Olenius M, Sellman G, Trevidic P.
PMID: 26894000
Plast Reconstr Surg Glob Open. 2016 Jan 07;3(12):e575. doi: 10.1097/GOX.0000000000000554. eCollection 2015 Dec.

Long-term follow-up data following 2 breast enhancement treatments with stabilized hyaluronic acid (HA) gel are limited. Although HA gel is no longer marketed for breast enhancement, there is a clinical need for information about follow-up of previously treated women....

Cite
Hedén P, Sarfati I, Clough K, et al. Safety and Efficacy of Stabilized Hyaluronic Acid Gel for Breast Enhancement. Plast Reconstr Surg Glob Open. 2016;3(12):e575doi: 10.1097/GOX.0000000000000554.
Hedén, P., Sarfati, I., Clough, K., Olenius, M., Sellman, G., & Trevidic, P. (2015). Safety and Efficacy of Stabilized Hyaluronic Acid Gel for Breast Enhancement. Plastic and reconstructive surgery. Global open, 3(12), e575. https://doi.org/10.1097/GOX.0000000000000554
Hedén, Per, et al. "Safety and Efficacy of Stabilized Hyaluronic Acid Gel for Breast Enhancement." Plastic and reconstructive surgery. Global open vol. 3,12 (2015): e575. doi: https://doi.org/10.1097/GOX.0000000000000554
Hedén P, Sarfati I, Clough K, Olenius M, Sellman G, Trevidic P. Safety and Efficacy of Stabilized Hyaluronic Acid Gel for Breast Enhancement. Plast Reconstr Surg Glob Open. 2016 Jan 07;3(12):e575. doi: 10.1097/GOX.0000000000000554. eCollection 2015 Dec. PMID: 26894000; PMCID: PMC4727684.
Copy Download .nbib Format: NLM
Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre.

Orphanet journal of rare diseases

Altman G, Hussain K, Green D, Strauss BJG, Wilcox G.
PMID: 34930395
Orphanet J Rare Dis. 2021 Dec 20;16(1):520. doi: 10.1186/s13023-021-02138-z.

BACKGROUND: Recently published European Society for Phenylketonuria (ESPKU) guidelines have recommended a lifelong diet with phenylalanine (Phe) control ≤ 600 μmol/L for phenylketonuria (PKU) patients. This study aimed to identify whether PKU adult patients are at a higher risk...

Cite
Altman G, Hussain K, Green D, et al. Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre. Orphanet J Rare Dis. 2021;16(1):520doi: 10.1186/s13023-021-02138-z.
Altman, G., Hussain, K., Green, D., Strauss, B. J. G., & Wilcox, G. (2021). Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre. Orphanet journal of rare diseases, 16(1), 520. https://doi.org/10.1186/s13023-021-02138-z
Altman, George, et al. "Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre." Orphanet journal of rare diseases vol. 16,1 (2021): 520. doi: https://doi.org/10.1186/s13023-021-02138-z
Altman G, Hussain K, Green D, Strauss BJG, Wilcox G. Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre. Orphanet J Rare Dis. 2021 Dec 20;16(1):520. doi: 10.1186/s13023-021-02138-z. PMID: 34930395; PMCID: PMC8691050.
Copy Download .nbib Format: NLM
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis.

Liver international : official journal of the International Association for the Study of the Liver

Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S.
PMID: 34846800
Liver Int. 2021 Nov 30; doi: 10.1111/liv.15121. Epub 2021 Nov 30.

BACKGROUND: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH).PATIENTS AND METHODS: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes...

Cite
Efe C, Lammert C, Taşçılar K, et al. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver Int. 2021;doi: 10.1111/liv.15121.
Efe, C., Lammert, C., Taşçılar, K., Dhanasekaran, R., Ebik, B., Higuera-de la Tijera, F., Calışkan, A. R., Peralta, M., Gerussi, A., Massoumi, H., Catana, A. M., Purnak, T., Rigamonti, C., Aldana, A. J. G., Khakoo, N., Nazal, L., Frager, S., Demir, N., Irak, K., Melekoğlu-Ellik, Z., Kacmaz, H., Balaban, Y., Atay, K., Eren, F., Alvares-da-Silva, M. R., Cristoferi, L., Urzua, �. �., Eşkazan, T., Magro, B., Snijders, R., Barutçu, S., Lytvyak, E., Zazueta, G. M., Demirezer-Bolat, A., Aydın, M., Heurgue-Berlot, A., De Martin, E., Ekin, N., Yıldırım, S., Yavuz, A., Bıyık, M., Narro, G. C., Kıyıcı, M., Akyıldız, M., Kahramanoğlu-Aksoy, E., Vincent, M., Carr, R. M., Günşar, F., Reyes, E. C., Harputluoğlu, M., Aloman, C., Gatselis, N. K., Üstündağ, Y., Brahm, J., Vargas, N. C. E., Güzelbulut, F., Garcia, S. R., Aguirre, J., Anders, M., Ratusnu, N., Hatemi, I., Mendizabal, M., Floreani, A., Fagiuoli, S., Silva, M., Idilman, R., Satapathy, S. K., Silveira, M., Drenth, J. P. H., Dalekos, G. N., N Assis, D., Björnsson, E., Boyer, J. L., Yoshida, E. M., Invernizzi, P., Levy, C., Montano-Loza, A. J., Schiano, T. D., Ridruejo, E., & Wahlin, S. (2021). Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver international : official journal of the International Association for the Study of the Liver, . https://doi.org/10.1111/liv.15121
Efe, Cumali, et al. "Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis." Liver international : official journal of the International Association for the Study of the Liver vol. (2021). doi: https://doi.org/10.1111/liv.15121
Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver Int. 2021 Nov 30; doi: 10.1111/liv.15121. Epub 2021 Nov 30. PMID: 34846800.
Copy Download .nbib Format: NLM
Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis.

Liver international : official journal of the International Association for the Study of the Liver

Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Miranda Zazueta G, Demirezer Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Castro Narro G, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Cerda Reyes E, Harputoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Chris Escajadillo Vargas N, Güzelbulut F, Ruiz Garcia S, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, Assis DN, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S.
PMID: 34846800
Liver Int. 2021 Nov 30; doi: 10.1111/liv.15121. Epub 2021 Nov 30.

BACKGROUND: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH).PATIENTS AND METHODS: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes...

Cite
Efe C, Lammert C, Taşçılar K, et al. Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis. Liver Int. 2021;doi: 10.1111/liv.15121.
Efe, C., Lammert, C., Taşçılar, K., Dhanasekaran, R., Ebik, B., Higuera-de la Tijera, F., Calışkan, A. R., Peralta, M., Gerussi, A., Massoumi, H., Catana, A. M., Purnak, T., Rigamonti, C., Gomez Aldana, A. J., Khakoo, N., Nazal, L., Frager, S., Demir, N., Irak, K., Melekoğlu Ellik, Z., Kacmaz, H., Balaban, Y., Atay, K., Eren, F., Alvares-da-Silva, M. R., Cristoferi, L., Urzua, �. �., Eşkazan, T., Magro, B., Snijders, R., Barutçu, S., Lytvyak, E., Miranda Zazueta, G., Demirezer Bolat, A., Aydın, M., Heurgue-Berlot, A., De Martin, E., Ekin, N., Yıldırım, S., Yavuz, A., Bıyık, M., Castro Narro, G., Kıyıcı, M., Akyıldız, M., Kahramanoğlu-Aksoy, E., Vincent, M., Carr, R. M., Günşar, F., Cerda Reyes, E., Harputoğlu, M., Aloman, C., Gatselis, N. K., Üstündağ, Y., Brahm, J., Chris Escajadillo Vargas, N., Güzelbulut, F., Ruiz Garcia, S., Aguirre, J., Anders, M., Ratusnu, N., Hatemi, I., Mendizabal, M., Floreani, A., Fagiuoli, S., Silva, M., Idilman, R., Satapathy, S. K., Silveira, M., Drenth, J. P. H., Dalekos, G. N., Assis, D. N., Björnsson, E., Boyer, J. L., Yoshida, E. M., Invernizzi, P., Levy, C., Montano-Loza, A. J., Schiano, T. D., Ridruejo, E., & Wahlin, S. (2021). Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis. Liver international : official journal of the International Association for the Study of the Liver, . https://doi.org/10.1111/liv.15121
Efe, Cumali, et al. "Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis." Liver international : official journal of the International Association for the Study of the Liver vol. (2021). doi: https://doi.org/10.1111/liv.15121
Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Miranda Zazueta G, Demirezer Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Castro Narro G, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Cerda Reyes E, Harputoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Chris Escajadillo Vargas N, Güzelbulut F, Ruiz Garcia S, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, Assis DN, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis. Liver Int. 2021 Nov 30; doi: 10.1111/liv.15121. Epub 2021 Nov 30. PMID: 34846800.
Copy Download .nbib Format: NLM
Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer.

Contemporary clinical trials

Klotz L, Andriole G, Cash H, Cooperberg M, Crawford ED, Emberton M, Gomez-Sancha F, Klein E, Lughezzani G, Marks L, Montorsi F, Salomon G, Sanchez-Salas R, Shore N, Taneja S.
PMID: 34728381
Contemp Clin Trials. 2021 Nov 01;112:106618. doi: 10.1016/j.cct.2021.106618. Epub 2021 Nov 01.

BACKGROUND: Micro-ultrasound (microUS) is a novel ultrasound-based imaging modality which has demonstrated the ability to visualize prostate cancer. Multiparametric MRI/ultrasound (mpMRI/US) fusion has recognized advantages for the performance of prostate biopsy, however, it encompasses additional cost, time and technical...

Cite
Klotz L, Andriole G, Cash H, et al. Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer. Contemp Clin Trials. 2021;112:106618doi: 10.1016/j.cct.2021.106618.
Klotz, L., Andriole, G., Cash, H., Cooperberg, M., Crawford, E. D., Emberton, M., Gomez-Sancha, F., Klein, E., Lughezzani, G., Marks, L., Montorsi, F., Salomon, G., Sanchez-Salas, R., Shore, N., & Taneja, S. (2021). Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer. Contemporary clinical trials, 112106618. https://doi.org/10.1016/j.cct.2021.106618
Klotz, Laurence, et al. "Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer." Contemporary clinical trials vol. 112 (2021): 106618. doi: https://doi.org/10.1016/j.cct.2021.106618
Klotz L, Andriole G, Cash H, Cooperberg M, Crawford ED, Emberton M, Gomez-Sancha F, Klein E, Lughezzani G, Marks L, Montorsi F, Salomon G, Sanchez-Salas R, Shore N, Taneja S. Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer. Contemp Clin Trials. 2021 Nov 01;112:106618. doi: 10.1016/j.cct.2021.106618. Epub 2021 Nov 01. PMID: 34728381.
Copy Download .nbib Format: NLM
Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy.

European urology oncology

Panebianco V, Villeirs G, Weinreb JC, Turkbey BI, Margolis DJ, Richenberg J, Schoots IG, Moore CM, Futterer J, Macura KJ, Oto A, Bittencourt LK, Haider MA, Salomon G, Tempany CM, Padhani AR, Barentsz JO.
PMID: 33582104
Eur Urol Oncol. 2021 Feb 10; doi: 10.1016/j.euo.2021.01.003. Epub 2021 Feb 10.

BACKGROUND: Imaging techniques are used to identify local recurrence of prostate cancer (PCa) for salvage therapy and to exclude metastases that should be addressed with systemic therapy. For magnetic resonance imaging (MRI), a reduction in the variability of acquisition,...

Cite
Panebianco V, Villeirs G, Weinreb JC, et al. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy. Eur Urol Oncol. 2021;doi: 10.1016/j.euo.2021.01.003.
Panebianco, V., Villeirs, G., Weinreb, J. C., Turkbey, B. I., Margolis, D. J., Richenberg, J., Schoots, I. G., Moore, C. M., Futterer, J., Macura, K. J., Oto, A., Bittencourt, L. K., Haider, M. A., Salomon, G., Tempany, C. M., Padhani, A. R., & Barentsz, J. O. (2021). Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy. European urology oncology, . https://doi.org/10.1016/j.euo.2021.01.003
Panebianco, Valeria, et al. "Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy." European urology oncology vol. (2021). doi: https://doi.org/10.1016/j.euo.2021.01.003
Panebianco V, Villeirs G, Weinreb JC, Turkbey BI, Margolis DJ, Richenberg J, Schoots IG, Moore CM, Futterer J, Macura KJ, Oto A, Bittencourt LK, Haider MA, Salomon G, Tempany CM, Padhani AR, Barentsz JO. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy. Eur Urol Oncol. 2021 Feb 10; doi: 10.1016/j.euo.2021.01.003. Epub 2021 Feb 10. PMID: 33582104.
Copy Download .nbib Format: NLM
SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors.

Bioorganic & medicinal chemistry letters

Yu W, Deng Y, Hopkins B, Huang X, Sloman D, Zhang H, Li D, McGowan MA, White C, Pu Q, Liu K, Fradera X, Lesburg CA, Martinot T, Doty A, Ferguson H, Nickbarg EB, Cheng M, Geda P, Song X, Smotrov N, Abeywickrema P, Andrews C, Chamberlin C, Mabrouk O, Curran P, Richards M, Saradjian P, Miller JR, Knemeyer I, Otte K, Vincent S, Sciammetta N, Bennett DJ, Han Y.
PMID: 34166782
Bioorg Med Chem Lett. 2021 Sep 01;47:128214. doi: 10.1016/j.bmcl.2021.128214. Epub 2021 Jun 21.

A novel series of IDO1 inhibitors have been identified with good IDO1 Hela cell and human whole blood activity. These inhibitors contain an indoline or a 3-azaindoline scaffold. Their structure-activity-relationship studies have been explored. Compounds 37 and 41 stood...

Cite
Yu W, Deng Y, Hopkins B, et al. SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors. Bioorg Med Chem Lett. 2021;47:128214doi: 10.1016/j.bmcl.2021.128214.
Yu, W., Deng, Y., Hopkins, B., Huang, X., Sloman, D., Zhang, H., Li, D., McGowan, M. A., White, C., Pu, Q., Liu, K., Fradera, X., Lesburg, C. A., Martinot, T., Doty, A., Ferguson, H., Nickbarg, E. B., Cheng, M., Geda, P., Song, X., Smotrov, N., Abeywickrema, P., Andrews, C., Chamberlin, C., Mabrouk, O., Curran, P., Richards, M., Saradjian, P., Miller, J. R., Knemeyer, I., Otte, K., Vincent, S., Sciammetta, N., Bennett, D. J., & Han, Y. (2021). SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors. Bioorganic & medicinal chemistry letters, 47128214. https://doi.org/10.1016/j.bmcl.2021.128214
Yu, Wensheng, et al. "SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors." Bioorganic & medicinal chemistry letters vol. 47 (2021): 128214. doi: https://doi.org/10.1016/j.bmcl.2021.128214
Yu W, Deng Y, Hopkins B, Huang X, Sloman D, Zhang H, Li D, McGowan MA, White C, Pu Q, Liu K, Fradera X, Lesburg CA, Martinot T, Doty A, Ferguson H, Nickbarg EB, Cheng M, Geda P, Song X, Smotrov N, Abeywickrema P, Andrews C, Chamberlin C, Mabrouk O, Curran P, Richards M, Saradjian P, Miller JR, Knemeyer I, Otte K, Vincent S, Sciammetta N, Bennett DJ, Han Y. SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors. Bioorg Med Chem Lett. 2021 Sep 01;47:128214. doi: 10.1016/j.bmcl.2021.128214. Epub 2021 Jun 21. PMID: 34166782.
Copy Download .nbib Format: NLM
The Treatment of Painful Diabetic Neuropathy.

Current diabetes reviews

Sloan G, Alam U, Selvarajah D, Tesfaye S.
PMID: 34238163
Curr Diabetes Rev. 2021 Jul 06; doi: 10.2174/1573399817666210707112413. Epub 2021 Jul 06.

Painful diabetic peripheral neuropathy (painful-DPN) is a highly prevalent and disabling condition, affecting up to one-third of patients with diabetes. This condition can have a profound impact, resulting in a low quality of life, disruption of employment, impaired sleep,...

Cite
Sloan G, Alam U, Selvarajah D, et al. The Treatment of Painful Diabetic Neuropathy. Curr Diabetes Rev. 2021;doi: 10.2174/1573399817666210707112413.
Sloan, G., Alam, U., Selvarajah, D., & Tesfaye, S. (2021). The Treatment of Painful Diabetic Neuropathy. Current diabetes reviews, . https://doi.org/10.2174/1573399817666210707112413
Sloan, Gordon, et al. "The Treatment of Painful Diabetic Neuropathy." Current diabetes reviews vol. (2021). doi: https://doi.org/10.2174/1573399817666210707112413
Sloan G, Alam U, Selvarajah D, Tesfaye S. The Treatment of Painful Diabetic Neuropathy. Curr Diabetes Rev. 2021 Jul 06; doi: 10.2174/1573399817666210707112413. Epub 2021 Jul 06. PMID: 34238163.
Copy Download .nbib Format: NLM
Mosaic NEK9 mutation, fibrous dysplasia and premature puberty in naevus comedonicus syndrome.

The British journal of dermatology

Carmignac V, Salomon G, Severino-Freire M, Duffourd Y, Chevarin M, Vabres P, Mazereeuw-Hautier J.
PMID: 34184242
Br J Dermatol. 2021 Dec;185(6):1247-1249. doi: 10.1111/bjd.20603. Epub 2021 Sep 07.

No abstract available.

Cite
Carmignac V, Salomon G, Severino-Freire M, et al. Mosaic NEK9 mutation, fibrous dysplasia and premature puberty in naevus comedonicus syndrome. Br J Dermatol. 2021;185(6):1247-1249doi: 10.1111/bjd.20603.
Carmignac, V., Salomon, G., Severino-Freire, M., Duffourd, Y., Chevarin, M., Vabres, P., & Mazereeuw-Hautier, J. (2021). Mosaic NEK9 mutation, fibrous dysplasia and premature puberty in naevus comedonicus syndrome. The British journal of dermatology, 185(6), 1247-1249. https://doi.org/10.1111/bjd.20603
Carmignac, V, et al. "Mosaic NEK9 mutation, fibrous dysplasia and premature puberty in naevus comedonicus syndrome." The British journal of dermatology vol. 185,6 (2021): 1247-1249. doi: https://doi.org/10.1111/bjd.20603
Carmignac V, Salomon G, Severino-Freire M, Duffourd Y, Chevarin M, Vabres P, Mazereeuw-Hautier J. Mosaic NEK9 mutation, fibrous dysplasia and premature puberty in naevus comedonicus syndrome. Br J Dermatol. 2021 Dec;185(6):1247-1249. doi: 10.1111/bjd.20603. Epub 2021 Sep 07. PMID: 34184242.
Copy Download .nbib Format: NLM
Showing 121 to 132 of 132 entries